Status:
WITHDRAWN
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Vogt Koyanagi Harada Disease
Serpiginous Choroiditis
Eligibility:
All Genders
25-60 years
Phase:
PHASE3
Brief Summary
Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual ac...
Eligibility Criteria
Inclusion
- Clinical Diagnose
- Patient Consent
- Chronic stage of inflammation
Exclusion
- only eye
- age lower than 30 yo.
- Systemic condition
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00407121
Start Date
December 1 2006
End Date
December 1 2006
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico, 04030